MTCYBP41

Across TCGA pan-cancer cohorts, MTCYBP41 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated MTCYBP41 data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher MTCYBP41 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MTCYBP41 expression acts as an unfavorable survival marker, although some lineages such as HNSC and LUSC show a favorable association.

CHOL, UVM, and HNSC are the cancer types where MTCYBP41 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Tertile	All	0.057	0.748	<.001	108	view →
UVM	DFS	Tertile	All	0.501	0.852	<.001	54	view →
HNSC	OS	Tertile	IV	0.870	0.697	.017	54	view →
BRCA	DFS	Tertile	All	0.866	0.910	.022	42	view →
GBM	OS	Tertile	All	0.058	0.416	<.001	18	view →
LGG	OS	Tertile	All	0.166	0.526	.004	18	view →
ACC	OS	Tertile	IV	0.327	0.633	.045	18	view →
LUSC	OS	Tertile	III,IV	0.780	0.266	.011	15	view →
LUAD	DFS	Tertile	All	0.626	0.316	.016	12	view →
THYM	OS	Tertile	All	0.849	0.982	.015	6	view →
OV	DFS	Quartile	III,IV	0.443	0.546	.015	6	view →
SKCM	OS	Median	IV	0.140	0.621	.044	5	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

MTCYBP41–CHOL (OS)

Open the CHOL breakdown →